Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 262

    1.

    Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients.

    Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhäusl W, Roden M.

    Diabetes. 2003 Jul;52(7):1792-8.PMID: 12829648 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.

    Damjanovic SS, Lalic NM, Pesko PM, Petakov MS, Jotic A, Miljic D, Lalic KS, Lukic L, Djurovic M, Djukic VB.

    J Clin Endocrinol Metab. 2006 Jul;91(7):2574-81. Epub 2006 Apr 18.PMID: 16621911 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

    Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285. PMID: 8621019 [PubMed - indexed for MEDLINE]Related articles

    4.

    Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.

    Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2963-72.PMID: 15181085 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients.

    Edén Engström B, Burman P, Holdstock C, Karlsson FA.

    J Clin Endocrinol Metab. 2003 Nov;88(11):5193-8.PMID: 14602749 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes.

    Erdmann J, Lippl F, Wagenpfeil S, Schusdziarra V.

    Diabetes. 2005 May;54(5):1371-8.PMID: 15855322 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

    Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.

    Diabetes. 2001 Aug;50(8):1807-12.PMID: 11473042 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.

    Naoumova RP, Cummings MH, Watts GF, Rendell NB, Taylor GW, Sönksen PH, Thompson GR.

    Eur J Clin Invest. 1996 Apr;26(4):332-40.PMID: 8732493 [PubMed - indexed for MEDLINE]Related articles

    10.

    Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure.

    Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, García-Naveiro R, Isidro ML, Villaverde P, García-Buela J.

    Kidney Int. 2005 Dec;68(6):2877-85.PMID: 16316365 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.

    Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, Ciani S, Fanelli A, Messeri G, Rotella CM.

    Diabet Med. 2000 Oct;17(10):713-9.PMID: 11110504 [PubMed - indexed for MEDLINE]Related articles

    12.

    Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans.

    Hunter SJ, Boyd AC, O'Harte FP, McKillop AM, Wiggam MI, Mooney MH, McCluskey JT, Lindsay JR, Ennis CN, Gamble R, Sheridan B, Barnett CR, McNulty H, Bell PM, Flatt PR.

    Diabetes. 2003 Feb;52(2):492-8.PMID: 12540626 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.

    Avogaro A, Valerio A, Gnudi L, Maran A, Miola M, Duner E, Marescotti C, Iori E, Tiengo A, Nosadini R.

    Diabetologia. 1992 Feb;35(2):129-38.PMID: 1547916 [PubMed - indexed for MEDLINE]Related articles

    15.

    Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

    Diabetes. 2001 Aug;50(8):1844-50.PMID: 11473047 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

    Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.

    Diabetes. 2003 Aug;52(8):1943-50.PMID: 12882909 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans.

    Anderwald-Stadler M, Krebs M, Promintzer M, Mandl M, Bischof MG, Nowotny P, Kästenbauer T, Luger A, Prager R, Anderwald C.

    Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1393-8. Epub 2007 Sep 4.PMID: 17785502 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls.

    Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A.

    Neuropsychopharmacology. 2005 Jun;30(6):1187-92.PMID: 15688086 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The ratio of leptin to adiponectin can be used as an index of insulin resistance.

    Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M.

    Metabolism. 2008 Feb;57(2):268-73.PMID: 18191059 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data